Merck: This Cancer-Drug Powerhouse Could Be a Core Dividend
A dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
Indices adjust divisors to reflect corporate actions and maintain continuity. This note covers the main reasons these changes occur.
28,369 articlesA dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
A new breed of data firms is staking its future on owning compute. This land data startup is buying GPUs and mapping ...
A hypothetical $1,000 XRP bet on election night would have endured wild swings and sharp turns. Here’s the latest rea...
A new stake lift from Bright Valley Capital highlights a high-stakes bet on Vipshop’s rebound. We break down what it ...
Stocks ride to record highs while bond yields climb. This article explains why treasury yields soaring that's driving...
Mexico’s president calls for FIFA to reconsider 2026 World Cup ticket prices amid affordability concerns as families ...
The IYE ETF sports a 2.2% yield while delivering a 131% gain over five years, a combination that challenges investors...
A leading manager weighs the case for broad crypto exposure after investors rejected crypto basket ETFs. Early demand...
New to crypto? This beginner-friendly guide walks you through the top cryptocurrencies for beginners, how to evaluate...
A premier eye care company delivers $5.1 billion in revenue, while a prominent investor quietly expands holdings. Her...
Ford CEO Jim Farley reveals his son will spend the summer fabricating rather than attending traditional classes, spot...
A $103 million exit during a 37% sector rally raises big questions for investors. This article explains what happened...